Ropivacaine

Form: Injection

Strength: 0.2% (2 mg/mL), 0.5% (5 mg/mL), 0.75% (7.5 mg/mL), 1.0% (10 mg/mL)

Reference Brands: Naropin (US & EU)

Category: Anaesthetics

Ropivacaine Hydrochloride is a long-acting amide-type local anesthetic widely used in regional anesthesia, including epidural, spinal, and peripheral nerve blocks. Ideal for surgical and postoperative pain management, it offers effective sensory block with reduced motor impairment and lower cardiotoxicity than bupivacaine. In the pharma B2B market, Ropivacaine is available as API and injectable formulations in 0.2%, 0.5%, 0.75%, and 1.0% strengths. It complies with USP, EP, and BP standards, making it suitable for regulatory markets like the EU and US. Bulk supply, contract manufacturing, and private labeling options are available for hospitals, clinics, and distributors.